Bill
HB 1385
HB 1385 establishes trust funds enabling terminal and rare disease patients in Florida to access experimental medical treatments outside standard approval processes.
HB 1385 would create a mechanism for establishing trust funds to support experimental treatments for patients with terminal conditions and life-threatening rare diseases in Florida. The bill appears designed to facilitate access to cutting-edge medical interventions that may not yet be fully approved through standard regulatory channels. The specific mechanics of the trust fund creation, funding sources, and eligibility criteria would depend on the bill's full text.
Access to experimental treatments represents a significant healthcare policy issue, particularly for patients with fatal diagnoses who have exhausted conventional options. This could expand treatment options for vulnerable populations but raises questions about regulatory oversight, patient protection, and the role of state government in medical decision-making. The balance between compassionate access and ensuring patient safety is a central concern in right-to-try legislation nationwide.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
